The R527H mutation in LMNA gene causes an increased sensitivity to ionizing radiation. 2008

Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
Department of Biology, University Roma Tre, Rome, Italy.

Mandibuloacral dysplasia type A (MADA; OMIM # 248370) is a premature ageing disease caused by the homozygous R527H mutation in the LMNA gene. At the cellular level, MADA is characterized by unprocessed prelamin A accumulation, nuclear architecture alterations, chromatin defects and increased incidence of apoptosis. In some progeroid laminopathies (e.g., HGPS) it has been demonstrated that such biochemical and morphological alterations are strongly linked with genomic instability. To test this also in MADA fibroblasts, their response to the ionising radiation-induced damage was analysed. We observed that their ability to repair the damage was significantly impaired, as demonstrated by the increased chromosome damage and the higher percentage of residual gamma-H2AX foci, corresponding to unrepaired DNA-damage sites. Moreover, MADA fibroblasts showed a markedly reduced phosphorylation of p53 at Ser15(S15) and a lower induction of p53 and CDKN1A proteins after irradiation, compared to the control cell line. Upon irradiation, we also detected differences in the expression of some p53 downstream target genes. In addition, MADA cells showed partial defects in the checkpoint response, particularly in G(1)/S transition. Our results indicate that accumulation of the lamin A precursor protein determines a defect in DNA damage response after X-ray exposure, supporting a crucial role of lamin A in regulating DNA repair process and cell cycle control.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011498 Protein Precursors Precursors, Protein
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins

Related Publications

Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
November 1997, International journal of radiation biology,
Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
January 2008, Anticancer research,
Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
October 2014, Journal of neurochemistry,
Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
November 1996, International journal of cancer,
Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
November 1996, Toxicology and applied pharmacology,
Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
November 2012, American journal of medical genetics. Part A,
Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
December 2007, Neuromuscular disorders : NMD,
Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
April 1999, Nature genetics,
Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
May 2009, Journal of cellular and molecular medicine,
Alessandra di Masi, and Maria Rosaria D'Apice, and Ruggero Ricordy, and Caterina Tanzarella, and Giuseppe Novelli
January 1977, Radiobiologiia,
Copied contents to your clipboard!